154 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
146
S-174
Symposium
13:30– 15:00
|
Hall Paris 2
TOPIC 3:
Psychotic disorders
Early recognition and intervention of psychosis
Chairs:
Mathias Zink, Germany
Paolo Fusar-Poli, United Kingdom
001
The clinical high risk state for psychosis: chal-
lenges for the next generation of research
Paolo Fusar-Poli, United Kingdom
002
Abnormal structural and functional brain imag-
ing during the early course of psychosis
Stefan Borgwardt, Switzerland
003
Cognitive and metacognitive deficits in the at
risk mental state for psychosis
Mathias Zink, Germany
004
Cognitive behavioural therapy for patients with
increased risk for psychosis
Mark van der Gaag, The Netherlands
S-175
Symposium
13:30– 15:00
|
Hall New York 1
TOPIC 22:
Community and social psychiatry
Recovery from schizophrenia: a symposium in mem-
ory of the work of Richard Warner MD
Chairs:
Peter Huxley, United Kingdom
Anne Krayer, United Kingdom
001
Updated review of recovery from schizophrenia
outcomes 2000–2015
Anne Krayer, United Kingdom
Peter Huxley, Sanjay Aryal
002
Building recovery supports and inclusion
opportunities through the economic development of
identity communities of people with serious mental
illnesses
Alan Rosen, Australia
003
Synergies between traditional cultural healing
factors and evidence based clinical interventions to
optimise outcomes for psychosis
Alan Rosen, Australia
004
The human-rights based approach to recovery
Michaela Amering, Austria
S-176
Symposium
13:30– 15:00
|
Hall New York 3
TOPIC 12:
Epidemiology and risk factors
Challenges in outpatient mental health care in
Europe – social, epidemiological, economical and
clinical issues
Chairs:
Dirk Richter, Switzerland
Hans-Joachim Salize, Germany
001
The current state of mental health care in Italy:
problems, perspectives and lessons to learn
Giulia Signorini, Italy
002
Social exclusion of persons with severe mental
illness in Switzerland
Dirk Richter, Switzerland
Holger Hoffmann
003
Adherence to antipsychotic medication in out-
patient schizophrenia care in Germany – effects on
hospital readmission and cost
Hans-Joachim Salize, Germany
004
Factors associated with the use of community
mental health services by schizophrenia-spectrum
patients in Málaga, Spain
Berta Moreno-Küstner, Spain
Antonio Bordallo, Mª Carmen Castillejos
S-177
Symposium
13:30– 15:00
|
Hall New York 2
TOPIC 18:
Pharmacotherapy
Neuroscience-based classification of psychothera-
peutic medications: a critical review
›
WPA Section: Pharmacopsychiatry
Chairs:
Hans-Jürgen Möller, Germany
Siegfried Kasper, Austria
001
Development of a neuroscience based nomen-
clature
Hans-Jürgen Möller, Germany
002
Why do we need a neuroscience-based nomen-
clature for psychotropic medication in psychiatry?
Marie Spies, Germany
003
The new proposed neuroscience-based nomen-
clature for psychotropic medications
Thomas Baghai, Germany